Novel immune checkpoint blocker approved for the treatment of advanced melanoma

Lorenzo Galluzzi, Guido Kroemer, Alexander Eggermont

    Research output: Contribution to journalEditorial

    32 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)e967147-1-e967147-5
    JournalOncoImmunology
    Volume3
    Issue number11
    DOIs
    Publication statusPublished - 2 Nov 2014

    Keywords

    • CTLA4
    • Keytruda™
    • PD-1
    • Yervoy™
    • ipilimumab
    • nivolumab

    Cite this